abstract |
The present invention provides a screening method for pain-relieving substances, said method characterized by the use of FLRT3 to select substances that inhibit the expression of FLRT3, or substances that inhibit transport of FLRT3 to the spinal cord. The present invention also provides a pharmaceutical composition for prevention or treatment of pain, said composition characterized by containing as an effective ingredient a substance that inhibits the expression of FLRT3, or a substance that inhibits transport of FLRT3 to the spinal cord. |